Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Productivity and Economic Advantages of Coupling Single-Pass Tangential Flow Filtration to Multi-Column Chromatography for Continuous Processing

Mark Schofield, Ph.D., Karl Rogler, Xhorxhi Gjoka, Engin Ayturk, Ph.D., and René Gantier, Ph.D.

Trends in Single-Use Mixing Technologies and Insight into Pall and Lonza Ibex® Solutions

Scheduling and Optimization of Biomanufacturing Activities in Multi-product Facilities with Disposable Technologies

Gloria Gadea-Lopez, Ph.D. is Director of Production and Business Systems at the Shire Lexington, John Maguireis the Associate Director of Manufacturing Systems at Shire’s Lexington and Megan Rabideau is a Manufacturing Systems Engineer at Shire’s Lexington

Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer

Bristol Myers Squibb

View All Featured Articles

Headline News

Pasritamig combination delivers 73% PSA response rate in advanced prostate cancer Phase I study

Spruce separates CRHX-101 programme into new endocrinology company Adrenyx Biosciences

Livdelzi improves ALP normalisation rates in Phase III PBC study

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Current and future applications of Near-infrared in Pharmaceutical and Biopharmaceutical Industry

Presented by Dr Erik Skibsted
10th January 2018

Assessing the Risk of Interaction Between Extractables and Leachable and Therapeutic Proteins

Presented by Andrew Teasdale, Senior Principal Scientist Impurity management and External Advocacy at AstraZeneca & Piet Christieans, PhD, Scientific Director at Nelson Lab
14th May 2020

Efficient execution of biologics manufacturing – The role of Finite Scheduling systems as part of sound business process from planning to floor operations.

Presented by Gloria Gadea-Lopez, Ph.D., John Maguire and Megan Rabideau
14th February 2018

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos